which glp 1 agonist is approved for weight loss Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia The Role of GLP-1RA Medications

Patients typically report feeling satisfied with smaller portions and experiencing reduced hunger between meals, which facilitates the caloric deficit necessary for weight loss

Active GLP-1 concentrations in portal vein significantly increased at 0.5 h and plateaued at 1 and 2 h after oral administration of d-allulose (1 g kg 1 ), returning to baseline at 3 h (Fig

Established cardiovascular disease

60 However, in humans, early studies demonstrated that GLP-2 administration for five weeks increased spinal BMD in people with short bowel syndrome, 62 but had limited overall bone benefits

However, the gastrointestinal motilityinhibiting effects of GLP-1 RAs, particularly delayed gastric emptying, have raised concerns regarding pulmonary aspiration during general anesthesia or procedural sedation [3]